Merck Says its New COVID-19 Pill Reduces the Risk of Death by Half For Some Patients
Merck and Ridgeback Biotherapeutics said Friday they’ve developed a drug that reduces the risk of hospitalization or death by around 50% for patients with mild or moderate cases of COVID-19. That is really good! It's kind of like half of a cure for the coronavirus.
Photo Credit: Danilo Alvesd